Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A5DJ
|
||||
| Former ID |
DIB001450
|
||||
| Drug Name |
Pancrecarb
|
||||
| Synonyms |
Pancrelipase (Digestive Care)
|
||||
| Indication | Pancreatic disease [ICD10:K85-K86] | NDA filed | [550604] | ||
| Company |
Digestive Care Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Pancreatic alpha-amylase | Target Info | Modulator | [550604] | |
| Chymotrypsin | Target Info | Modulator | [549592], [550162] | ||
| Triacylglycerol lipase, pancreatic | Target Info | Modulator | [550604] | ||
| BioCyc Pathway | Triacylglycerol degradation | ||||
| Retinol biosynthesis | |||||
| Reactome | Retinoid metabolism and transport | ||||
| References | |||||
| Ref 549592 | US patent application no. 2012,0251,516, PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND/OR CHYMOTRYPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VANILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCTION AGENT. | ||||
| Ref 550162 | EP patent application no. 2490711, A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent). | ||||
| Ref 550604 | Clinical pipeline report, company report or official report of Digestive Care. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.